53 related articles for article (PubMed ID: 7905741)
21. The value of preserving HIV-specific immune responses.
Kaufmann DE; Rosenberg ES
J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulation in HIV-1 infection in the HAART era.
Imami N; Sullivan AK; Gotch FM
J HIV Ther; 2001 Nov; 6(4):77-84. PubMed ID: 11740408
[No Abstract] [Full Text] [Related]
23. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.
Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P
Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642
[TBL] [Abstract][Full Text] [Related]
24. [Control of cytotoxic T cell responses].
Autran B
Ann Rech Vet; 1992; 23(3):301-4. PubMed ID: 1384418
[No Abstract] [Full Text] [Related]
25. [Cytokines and HIV infection].
Emilie D
Pathol Biol (Paris); 1993 May; 41(5):449-52. PubMed ID: 8414676
[No Abstract] [Full Text] [Related]
26. AIDS and immune dysfunction. Alternative etiologic mechanisms.
del Guercio P
Contrib Microbiol Immunol; 1989; 11():289-304. PubMed ID: 2573482
[No Abstract] [Full Text] [Related]
27. What's new in HIV/AIDS. Protective immunity in HIV infection: where do we stand?
Draenert R; Goebel FD
Infection; 2004 Aug; 32(4):250-2. PubMed ID: 15293085
[TBL] [Abstract][Full Text] [Related]
28. Recent developments in theories of pathogenesis of AIDS.
Antia R; Halloran ME
Trends Microbiol; 1996 Jul; 4(7):282-5. PubMed ID: 8829337
[TBL] [Abstract][Full Text] [Related]
29. HIV and children: the developing immune system fights back.
Feeney ME
West Indian Med J; 2004 Oct; 53(5):359-62. PubMed ID: 15675505
[TBL] [Abstract][Full Text] [Related]
30. Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells?
Finkel TH; Banda NK
Curr Opin Immunol; 1994 Aug; 6(4):605-15. PubMed ID: 7946050
[TBL] [Abstract][Full Text] [Related]
31. HIV-specific cytotoxic T lymphocytes and their possible implications in the future vaccine against AIDS.
Langlade-Demoyen P; Hoffenbach A
Res Immunol; 1989 Jan; 140(1):95-9; discussion 119-20. PubMed ID: 2567045
[No Abstract] [Full Text] [Related]
32. Programmed cell death and AIDS: from hypothesis to experiment.
Ameisen JC
Immunol Today; 1992 Oct; 13(10):388-91. PubMed ID: 1358091
[TBL] [Abstract][Full Text] [Related]
33. Immune reconstitution for HIV disease.
Bridges SH
Antibiot Chemother (1971); 1996; 48():233-9. PubMed ID: 8726530
[No Abstract] [Full Text] [Related]
34. Immunobiological aspects of HIV treatment.
Dalgleish AG
Curr Opin Immunol; 1993 Aug; 5(4):608-14. PubMed ID: 8105805
[TBL] [Abstract][Full Text] [Related]
35. Why can't cytotoxic T cells handle HIV?
Bevan MJ; Braciale TJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5765-7. PubMed ID: 7597026
[No Abstract] [Full Text] [Related]
36. Serologic and immunologic markers in the course of HIV-1 infection.
de Wolf F; Lange JM
Clin Dermatol; 1991; 9(1):1-11. PubMed ID: 1682023
[No Abstract] [Full Text] [Related]
37. CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection.
Riddell SR; Gilbert MJ; Greenberg PD
Curr Opin Immunol; 1993 Aug; 5(4):484-91. PubMed ID: 8216922
[TBL] [Abstract][Full Text] [Related]
38. CD4 and the immunopathology of AIDS.
Kornfeld H
Am J Respir Cell Mol Biol; 1989 Nov; 1(5):349-50. PubMed ID: 2576908
[No Abstract] [Full Text] [Related]
39. Immunological characteristics and potential approaches to immunotherapy of HIV infection.
Hersh EM; Petersen EA; Yocum DE; Gorman SR; Darragh MJ; Gschwind CR; Brewton GW; Reuben JA
Recent Results Cancer Res; 1988; 112():17-26. PubMed ID: 2849786
[No Abstract] [Full Text] [Related]
40. Can AIDS be prevented by T-cell vaccination?
Atlan H; Gersten MJ; Salk PL; Salk J
Immunol Today; 1993 May; 14(5):200-2. PubMed ID: 8517917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
